At Close: 4:00 PM
Moderna Stock Price Graph
Moderna Stock Price Today
Moderna, Inc. (MRNA) stock declined over -0.58% intraday to trade at $77.72 a share on NASDAQ. The stock opened with a loss of -3.34% at $75.90 and touched an intraday high of $76.56, falling -1.02% against the last close of $78.52. The Moderna, Inc. in stock market went to a low of $71.55 during the session.
Moderna Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
Moderna Stock Price History Chart
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Frequently Asked Questions
What is the current Moderna, Inc. (MRNA) stock price?
Moderna, Inc. (NASDAQ: MRNA) stock price is $77.72 in the last trading session. During the trading session, MRNA stock reached the peak price of $76.56 while $71.55 was the lowest point it dropped to. The percentage change in MRNA stock occurred in the recent session was -0.58% while the dollar amount for the price change in MRNA stock was -$0.45.
MRNA's industry and sector of operation?
The NASDAQ listed MRNA is part of Biotechnology industry that operates in the broader Healthcare sector. Moderna, Inc. , a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally.
Who are the executives of MRNA?
Mr. Stephane Bancel
Chief Executive Officer & Director
Ms. Lavina Talukdar CFA
Senior Vice President & Head of Investor Relations
Ms. Shannon Thyme Klinger
Chief Legal Officer & Corporation Sec.
Dr. Noubar B. Afeyan Ph.D.
Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board
How MRNA did perform over past 52-week?
MRNA's closing price is 0.17% higher than its 52-week low of $71.55 where as its distance from 52-week high of $217.25 is -0.38%.
How many employees does MRNA have?
Number of MRNA employees currently stands at N/A. MRNA operates from 200 Technology Square, Cambridge, MA 02139, US.
Link for MRNA official website?
Official Website of MRNA is: https://www.modernatx.com
How do I contact MRNA?
How many shares of MRNA are traded daily?
MRNA stock volume for the day was 2868207.00 shares. The average number of MRNA shares traded daily for last 3 months was 4.06 Million.
What is the market cap of MRNA currently?
The market value of MRNA currently stands at $29.63 Billion with its latest stock price at $77.72 and N/A of its shares outstanding.